Home LiteratureArticle Details
PMID: 41639719 Published · epublish English

The inhibition of the MRN complex by Mirin radiosensitizes particularly HPV-negative HNSCC cell lines.

Cancer cell international ·Vol. 26 ·No. 1 ·2026-02-04

Hildebrand LS, Mehravani BP, Khalifa M, Schiller P, Langkrär J, Jost T, Fietkau R, Distel LV

Abstract

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is a relevant cancer entity with two main risk factors. Human papilloma virus (HPV)-positive ones are induced by virus infection and generally have a good prognosis due to their chemo- and radiosensitivity. In contrast, HPV-negative HNSCCs are primarily caused by tobacco and alcohol abuse; patients have a poor prognosis resulting in the need of innovative targeted and combinatory treatment options. Therefore, we combined the Mre11-Rad50-Nbs1 (MRN) inhibitor Mirin with ionizing radiation (IR). Our hypothesis is that the inhibition of the cancer cells’ DNA damage response (DDR) by Mirin leads to reduced repair capacity and a radiosensitization of the cancer cells. METHODS: We investigated the effect of Mirin in combination with IR on five HPV-negative and two HPV-positive HNSCC cell lines and one primary fibroblast cell line - serving as healthy control - in several functional assays. RESULTS: We suggest – on the one hand - that Mirin shows a trend towards radiosensitizing effects regarding cell death, cell cycle distribution, colony formation, and deoxyribonucleic acid (DNA) damage in HPV-negative HNSCC cell lines but not in HPV-positive ones. On the other hand, the healthy control was nearly unaffected by the combinatory treatment which indicates low side effects. CONCLUSIONS: It is useful to generate a deeper insight into the underlying cellular mechanisms of Mirin response in future studies and further validate Mirin’s potential radiosensitizing effect in HPV-negative HNSCCs.

Keywords
DNA damage response Head and neck squamous cell carcinoma Human papilloma virus MRN complex Mirin Radiosensitization Radiotherapy Small molecule inhibitor
Article Info
Journal
Cancer cell international
Abbr.
Cancer Cell Int
ISSN
1475-2867
Published
2026-02-04
Language
English
Country/Region
England
NLM ID
101139795
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com